1
|
Patel K, Rydzewski NR, Schott EE, Cooley-Zgela TC, Ning H, Cheng JY, Pinto PA, Salerno KE, Lindenberg L, Mena E, Turkbey B, Choyke P, Citrin DE. A Phase I Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e426-e427. [PMID: 37785396 DOI: 10.1016/j.ijrobp.2023.06.1587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Locally recurrent prostate cancer after radiotherapy (RT) is an increasingly recognized entity with no standard management. NCT03253744 was a phase I trial with a primary objective of identifying the maximally tolerated dose (MTD) of a course of image-guided, focal, salvage stereotactic body radiotherapy (SBRT) for patients with local recurrence after prior definitive RT. Additional objectives included biochemical control and imaging response on mpMRI and 18F-DCFPyL (PSMA) PET/CT. MATERIALS/METHODS SBRT was prescribed to three dose levels (DLs): 40Gy (DL1), 42.5Gy (DL2), and 45Gy (DL3) in 5 fractions. The prescription dose was delivered to a PTV defined by mpMRI and PSMA imaging and biopsy confirmed tumor volume. Dose escalation followed a 3+3 design with a 3-patient expansion at the MTD. Toxicities above baseline were scored using CTCAE v5.0 criteria for two years after completion of SBRT. Escalation was halted if 2 dose limiting toxicities (DLTs) were observed. DLTs were defined as any persistent (>4 days) grade 3 toxicity occurring within the first 3 weeks after SBRT, and any grade 3 GU or grade 4 GI toxicity thereafter. Imaging response was compared between baseline and 6-months by the Wilcoxon signed rank test. RESULTS Between 08/2018 and 05/2022, 8 patients underwent salvage SBRT to 11 intraprostatic lesions with a median follow-up of 27 months. No DLTs were observed on DL1. Two patients were enrolled on DL2 and both experienced grade 3 GU toxicities, prompting de-escalation and expansion (n = 6) on DL1, the MTD. The most common toxicities were grade 2 GU toxicities: acute urinary urgency/frequency, acute weak urinary stream, and noninfective cystitis. One patient at DL1 had a self-limited episode of grade 2 GI toxicity (proctitis). No grade 3 GI toxicities were observed. All but two patients achieved an undetectable PSA nadir. Only one of these experienced biochemical failure (nadir + 2.0) at 33 months with suspicion of distant metastatic failure on restaging PET/CT. Imaging response was demonstrated by MRI in all lesions with heterogeneity in volumetric response (6% to 100%). A significant (p<0.01) response on PSMA PET/CT was observed for all measured parameters (SUVMax, SUVMean, GTVPSMA, Total Lesion PSMA [SUVMean × GTVPSMA]). Of the 11 lesions, 1 (9%) demonstrated a complete response (CR) by MRI and 9 (82%) by PSMA PET/CT. A single lesion increased in volume by 0.06 cc (16%) at 6-month PSMA PET/CT compared to baseline in the only patient who did not achieve an undetectable PSA nadir and did not have imaging suggestive of distant failure. CONCLUSION On this phase I dose escalation study of salvage SBRT for isolated intraprostatic local failure after definitive RT, the MTD was 40Gy in 5 fractions. producing a 100% 24-month bPFS, with one late failure at 33 months occurring after the 24-month study period. The most frequent clinically significant toxicity was late grade 2 GU toxicity. Imaging response was demonstrated in all lesions on MRI and PSMA PET/CT with exception of a single lesion.
Collapse
Affiliation(s)
- K Patel
- Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| | - N R Rydzewski
- Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| | - E E Schott
- Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| | - T C Cooley-Zgela
- Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| | - H Ning
- Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| | - J Y Cheng
- Center for Cancer Research, National Cancer Institute, Bethesda, MD
| | - P A Pinto
- Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| | - K E Salerno
- Center for Cancer Research, National Cancer Institute, Bethesda, MD
| | - L Lindenberg
- Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD
| | - E Mena
- Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD
| | - B Turkbey
- Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD
| | - P Choyke
- Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
| | - D E Citrin
- Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
| |
Collapse
|
2
|
Zhu Z, Liu Y, Xu H, Ning H, Xia Y, Shen L. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature. J Cardiothorac Surg 2023; 18:254. [PMID: 37653509 PMCID: PMC10472660 DOI: 10.1186/s13019-023-02349-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Accepted: 08/09/2023] [Indexed: 09/02/2023] Open
Abstract
BACKGROUND Combined large cell neuroendocrine carcinoma (C-LCNEC) has a poor prognosis and there is no consensus about the treatment regimen for both LCNEC and C-LCNEC patients. CASE PRESENTATION The patient was a 47-year-old female who received surgical resection. The postoperative histology and staging of the tumor suggested C-LCNEC with adenocarcinoma and squamous cell carcinoma and T2aN0M0 stage IB. Next-generation sequencing test showed KIF5B/RET fusion mutation without EGFR, ALK, RB1, and TP53 alterations. Adjuvant chemotherapy with 4-cycle docetaxel plus carboplatin was given and brain metastasis occurred after 10 months. CONCLUSIONS C-LCNEC with adenocarcinoma and squamous cell carcinoma is rare and highly aggressive cancer. Surgical resection and adjuvant chemotherapy with SCLC regimen may improve the disease-free survival and overall survival. The accumulation of similar cases will clarify the profile and management of the disease.
Collapse
Affiliation(s)
- Zirui Zhu
- Department of Thoracic Surgery, Hainan hospital of PLA general hospital, Sanya, 572013, PR China
| | - You Liu
- Department of Pathology, Hainan hospital of PLA general hospital, Sanya, PR China
| | - Hengliang Xu
- Department of Thoracic Surgery, Hainan hospital of PLA general hospital, Sanya, 572013, PR China
| | - Haoyong Ning
- Department of Pathology, Hainan hospital of PLA general hospital, Sanya, PR China
| | - Yanmin Xia
- Department of Thoracic Surgery, Hainan hospital of PLA general hospital, Sanya, 572013, PR China
| | - Leilei Shen
- Department of Thoracic Surgery, Hainan hospital of PLA general hospital, Sanya, 572013, PR China.
| |
Collapse
|
3
|
Beckmann R, Ning H, Cheng J, Zhuge Y, Patel K, Guion P, Zgela TC, Nathan D, Schott E, Citrin D, Salerno K. Comparison of Nodal CTV Coverage with Alignment to Bladder-Rectal Interface vs. Pelvic Bone in Post-Prostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
4
|
Patel K, Rowe L, Schott E, Zgela T, Ning H, Turkbey B, Choyke P, Lindenberg L, Pinto P, Wood B, Sowalsky A, Shih J, Salerno K, Citrin D. A Phase I Trial of Highly Conformal, Hypofractionated Post Prostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Ning H, Yiqun Z, Jianfei W. Multi-omics prognosis predictive model of metastatic urothelial carcinoma (mUCs) with immunotherapy. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01207-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Wang K, Miao Y, Ning H, Guo F, Bian Y, Wang Q, Sun C, Qi X, Qiu F. Acute-onset paraneoplastic cerebellar degeneration secondary to neuroendocrine carcinoma with atypical prognosis: a case report. J Int Med Res 2021; 49:300060521992231. [PMID: 33583245 PMCID: PMC7890730 DOI: 10.1177/0300060521992231] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Paraneoplastic cerebellar degeneration (PCD) is a neurological syndrome that is likely caused by tumor-induced autoimmunity against the cerebellum. Neuroendocrine carcinoma (NEC) is a type of neoplasm with high-grade malignant histology and biological behavior. The prognosis for both PCD and NEC is typically poor. We report a case of PCD secondary to metastatic NEC in the lymph nodes, with an unknown primary origin. The case presented acute cerebellar manifestations with typical neuroimaging findings, but with atypical prognosis after lymph node dissection. Neurological symptoms can provide clues to potential tumors, and early antitumor treatment may have contributed to the positive prognosis of PCD secondary to NEC in the present case.
Collapse
Affiliation(s)
- Kunyu Wang
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yan Miao
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Haoyong Ning
- Department of Pathology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Feng Guo
- Department of Nuclear Medicine, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yang Bian
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Qingqing Wang
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Chenjing Sun
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Xiaokun Qi
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Feng Qiu
- Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| |
Collapse
|
7
|
Li F, Ning H, Duan X, Chen Z, Xu L. Effect of dietary l-arginine of broiler breeder hens on embryonic development, apparent metabolism, and immunity of offspring. Domest Anim Endocrinol 2021; 74:106537. [PMID: 32891986 DOI: 10.1016/j.domaniend.2020.106537] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Revised: 08/05/2020] [Accepted: 08/06/2020] [Indexed: 11/18/2022]
Abstract
This study investigated the effects of supplemented l-arginine (l-Arg) in broiler breeder hens' diets on the embryonic development and physiological changes of offspring during the hatching period. A total of 480 35-wk-old healthy female Arbor Acres broiler breeders were randomly divided into 6 groups and fed a corn and soybean meal diet with 6 digestible Arg levels (0.96%, 1.16%, 1.35%, 1.55%, 1.74%, and 1.93%). After a 10-wk experiment, eggs were collected for incubation. At embryonic day (E) 11 to E21, eggs, embryos, and organs (liver, breast muscle, and thigh muscle) were weighed. Total protein, urea nitrogen, creatinine, cholesterol, and triglyceride in plasma, were measured. Plasma level of immunoglobulin G (IgG), immunoglobulin M (IgM), and nitric oxide synthase (NOS) were measured at E13, E17, and E21. Messenger RNA expression of carbamoyl phosphate synthase I (CPS1), ornithine transcarbamylase (OTC), and argininosuccinate synthase (ASS) in liver and breast muscle tissues was assessed at E13, E17, and E21. The results showed that 1.16% Arg in maternal diet increased egg weight (P < 0.05). The level of Arg in maternal diet has a significant effect on organ index and embryo weight of multiple embryonic days (P < 0.05). Embryonic plasma total protein concentration was significantly affected by maternal dietary Arg level (P < 0.05) and exhibited quadratic responses at E11, E15, E17, and E21 (P < 0.01). Plasma urea nitrogen, creatinine, triglyceride, and cholesterol level were also significantly affected by the level of maternal Arg at different embryonic ages (P < 0.05). Dietary digestible Arg levels quadratically influenced plasma urea nitrogen level at E21 (P < 0.05) and cholesterol concentration at E17 and E19 (P < 0.01). L-Arg supplementation in maternal diet significantly improved the IgG level at E17 and E21 (1.16%, 1.35%, 1.55%, and 1.74%; P < 0.05), the IgM level at E13 (1.35%, 1.55%, 1.74%, and 1.93%) and E17 (P < 0.05) and the NOS level at E13, E17, and E21 (P < 0.05). Maternal dietary L-Arg supplementation significantly improved the expression of CPS1 gene, OTC gene (1.16%, 1.35%, and 1.55%), and ASS gene (1.35% and 1.55%) in the liver (P < 0.05), and also enhanced the CPS1 gene (except 1.35%) and OTC gene (1.55% and 1.74%) expression in the breast muscle (P < 0.05). In conclusion, maternal Arg level affected the embryonic development of offspring and regulated the apparent metabolic programming and immunity state of the embryo. Arginine level of 1.55% in hens' diet was beneficial to the protein synthesis and immunity of the offspring in the embryonic period, and it was recommended to obtain healthy offspring.
Collapse
Affiliation(s)
- F Li
- Institute of Animal Nutrition, Northeast Agricultural University, Harbin, China
| | - H Ning
- Institute of Animal Nutrition, Northeast Agricultural University, Harbin, China
| | - X Duan
- Institute of Animal Nutrition, Northeast Agricultural University, Harbin, China
| | - Z Chen
- Institute of Animal Nutrition, Northeast Agricultural University, Harbin, China
| | - L Xu
- Institute of Animal Nutrition, Northeast Agricultural University, Harbin, China.
| |
Collapse
|
8
|
Ning H, Mehio O, Buchhold M, Kurumaji T, Refael G, Checkelsky JG, Hsieh D. Signatures of Ultrafast Reversal of Excitonic Order in Ta_{2}NiSe_{5}. Phys Rev Lett 2020; 125:267602. [PMID: 33449742 DOI: 10.1103/physrevlett.125.267602] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 08/25/2020] [Accepted: 11/24/2020] [Indexed: 06/12/2023]
Abstract
In the presence of electron-phonon coupling, an excitonic insulator harbors two degenerate ground states described by an Ising-type order parameter. Starting from a microscopic Hamiltonian, we derive the equations of motion for the Ising order parameter in the phonon coupled excitonic insulator Ta_{2}NiSe_{5} and show that it can be controllably reversed on ultrashort timescales using appropriate laser pulse sequences. Using a combination of theory and time-resolved optical reflectivity measurements, we report evidence of such order parameter reversal in Ta_{2}NiSe_{5} based on the anomalous behavior of its coherently excited order-parameter-coupled phonons. Our Letter expands the field of ultrafast order parameter control beyond spin and charge ordered materials.
Collapse
Affiliation(s)
- H Ning
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - O Mehio
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - M Buchhold
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - T Kurumaji
- Department of Physics, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA
| | - G Refael
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - J G Checkelsky
- Department of Physics, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA
| | - D Hsieh
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| |
Collapse
|
9
|
Ron A, Chaudhary S, Zhang G, Ning H, Zoghlin E, Wilson SD, Averitt RD, Refael G, Hsieh D. Ultrafast Enhancement of Ferromagnetic Spin Exchange Induced by Ligand-to-Metal Charge Transfer. Phys Rev Lett 2020; 125:197203. [PMID: 33216570 DOI: 10.1103/physrevlett.125.197203] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Revised: 08/17/2020] [Accepted: 10/02/2020] [Indexed: 06/11/2023]
Abstract
We theoretically predict and experimentally demonstrate a nonthermal pathway to optically enhance superexchange interaction energies in a material based on exciting ligand-to-metal charge-transfer transitions, which introduces lower-order virtual hopping contributions that are absent in the ground state. We demonstrate this effect in the layered ferromagnetic insulator CrSiTe_{3} by exciting Te-to-Cr charge-transfer transitions using ultrashort laser pulses and detecting coherent phonon oscillations that are impulsively generated by superexchange enhancement via magneto-elastic coupling. This mechanism kicks in below the temperature scale where short-range in-plane spin correlations begin to develop and disappears when the excitation energy is tuned away from the charge-transfer resonance, consistent with our predictions.
Collapse
Affiliation(s)
- A Ron
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
- Raymond and Beverly Sackler School of Physics and Astronomy, Tel-Aviv University, Tel Aviv, 69978, Israel
| | - S Chaudhary
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
| | - G Zhang
- Department of Physics, University of California, San Diego, La Jolla, California 92093, USA
| | - H Ning
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
| | - E Zoghlin
- Materials Department, University of California, Santa Barbara, Santa Barbara, California 93106, USA
| | - S D Wilson
- Materials Department, University of California, Santa Barbara, Santa Barbara, California 93106, USA
| | - R D Averitt
- Department of Physics, University of California, San Diego, La Jolla, California 92093, USA
| | - G Refael
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
| | - D Hsieh
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Institute for Quantum Information and Matter, California Institute of Technology, Pasadena, California 91125, USA
| |
Collapse
|
10
|
Beckmann R, Ning H, Cheng J, Roy S, Guion P, Cooley Zgela T, Schott E, Citrin D, Salerno K. Image Guidance with Alignment To Bladder-Rectal Interface Versus Pelvic Bone In Post-Prostatectomy Radiotherapy: Implications For Concurrent Nodal Irradiation. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Masoudi S, Harmon S, Mehralivand S, Walker S, Ning H, Choyke P, Turkbey B, Citrin D. Cross Modality Domain Adaptation To Generate Pelvic Magnetic Resonance Images From Computed Tomography Simulation For More Accurate Prostate Delineation In Radiotherapy Treatment. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.572] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Mandia J, Ning H, Salerno K, Escorcia F, Citrin D, Rowe L. Image Guidance in Radiation Therapy for Prostate Cancer: Results of Patterns of Practice Survey. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Mandia J, Ning H, Salerno K, Escorcia F, Citrin D, Rowe L. Bowel and Bladder Reproducibility in Radiation Therapy for Prostate Cancer: Results of Patterns of Practice Survey. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
Abstract
The aim of the study was to assess the diagnostic value of high b-value (2000 s/mm) diffusion-weighted imaging (DWI) in differentiating malignant from benign thyroid micronodules.Consecutive patients with thyroid micronodules scheduled for Ultrasound (US)-guided fine-needle aspiration biopsy (FNAB) or surgery were underwent high b-value DWI with 3 b-values: 0, 800, and 2000 s/mm. Signal intensity ratios (SIRs) of thyroid micronodules to adjacent normal thyroid tissue on DWI were measured as SIRb0, SIRb800 and SIRb2000. Apparent diffusion coefficients (ADCs) according to the three different b-values were acquired as: ADCb0-800, ADCb0-2000 and ADCb0-800-2000. The 6 diagnostic indicators were evaluated by receiver operating characteristic (ROC) and diagnostic ability was compared between the high b-value DWI and US.Sixty-two malignant thyroid micronodules (48 patients, 13 men and 35 women, aged 44.8 ± 11.7 years) and 57 benign thyroid micronodules (40 patients, 6 men and 34 women, aged 49.6 ± 12.5 years) were enrolled into the final statistical analysis. Among the alone diagnostic indicators, SIRb2000 had the highest diagnostic ability in differentiating malignant from benign thyroid micronodules with area under curve (AUC) of 0.975, sensitivity of 90.32% and specificity of 96.49%. Compared to US, SIRb2000 had a significantly better diagnostic ability US for thyroid micronodules (P < .001) with dramatically raised positive predict value (96.6% vs 78.9%) and reduced false-positive rate (3.51% vs 26.32%).High b-value (2000 s/mm) DWI can contribute to differentiating malignant from benign thyroid micronodules.
Collapse
Affiliation(s)
| | | | | | | | | | - Yuanyuan Lu
- Department of Ultrasound, Chinese Navy General Hospital of PLA, Fucheng Road
| | - Qinglei Shi
- Scientific Marketing, Siemens Healthcare Ltd., Zhonghuannan Road, Beijing, China
| |
Collapse
|
15
|
Ning H, Wu Q, Han D, Yao T, Wang J, Lu W, Lv S, Jia Q, Li X. Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease. Neuropathol Appl Neurobiol 2018; 45:398-409. [PMID: 30346044 PMCID: PMC7380054 DOI: 10.1111/nan.12524] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Accepted: 10/15/2018] [Indexed: 12/24/2022]
Abstract
BACKGROUND The prognostic significance of misfolded α-synuclein (α-Syn) aggregates in Parkinson's disease (PD) has not been well investigated. The aim of this study was to reveal the relationship between misfolded α-Syn aggregate concentration in cerebrospinal fluid (CSF) and cognitive decline risk in PD. METHODS A total of 278 patients with PD were retrospectively included. They were diagnosed between 2011 and 2013. The end-point was 2016, and the follow-up period was 54.3 ± 10.0 months. Cognitive decline was defined as a 4-point decrease in the Mini-Mental State Examination score during follow-up. Misfolded α-Syn aggregate concentration in baseline CSF was measured using the protein misfolding cyclic amplification (PMCA) technique. Time to reach 50% of the maximum fluorescence value was recorded. RESULTS The PMCA technique successfully detected the level of misfolded α-Syn aggregates in CSF with a sensitivity of 85.3% and a specificity of 91.4%. The time to reach 50% of the maximum fluorescence value was shorter in the patients with cognitive decline than in the patients without cognitive decline (190.7 ± 40.1 h vs. 240.8 ± 45.6 h, P < 0.001). Multifactorial Cox regression analysis revealed that reaching 50% of the maximum fluorescence value in ≤219 h at baseline was associated with increased risk of cognitive decline during the follow-up (HR: 4.90, 95% CI: 2.75-8.74, P < 0.001). CONCLUSION Baseline concentration of misfolded α-Syn aggregates in CSF measured by the PMCA technique predicts risk of cognitive decline in PD.
Collapse
Affiliation(s)
- H Ning
- Department of Digestive Diseases,, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Q Wu
- Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - D Han
- Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - T Yao
- Department of Digestive Diseases,, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Wang
- Department of Digestive Diseases,, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - W Lu
- Department of Digestive Diseases,, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - S Lv
- Department of Digestive Diseases,, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Q Jia
- Department of Digestive Diseases,, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - X Li
- Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
16
|
Horn A, Smith C, Harmon S, Ning H, Pomper M, Schott E, Cooley-Zgela T, Choyke P, Mena Gonzalez E, Turkbey B, Citrin D, Lindenberg L, Rowe L. Evaluating Patterns of Prostate Cancer Recurrence on 18F-DCFBC PET/CT Imaging in Relationship to RTOG Consensus Post-prostatectomy and Pelvic Lymph Node Treatment Volumes. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Wang Q, Guo Y, Zhang J, Shi L, Ning H, Zhang X, Lu Y. Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules. PLoS One 2018; 13:e0200270. [PMID: 30020961 PMCID: PMC6051619 DOI: 10.1371/journal.pone.0200270] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2018] [Accepted: 06/23/2018] [Indexed: 11/19/2022] Open
Abstract
Purpose The aim of the study was to evaluate the role of high b-value (2000 sec/mm2) diffusion-weighted imaging (DWI) by using Readout Segmentation of Long Variable Echo-trains (RESOLVE) in differentiating papillary thyroid carcinomas (PTCs) and papillary thyroid microcarcinomas (PTMCs) from benign thyroid nodules. Materials and methods Consecutive patients with thyroid nodules scheduled for surgery underwent high b-value DWI with 3 b-values: 0, 800 and 2000 sec/mm2. Signal intensity ratios (SIRs) of thyroid nodules to adjacent normal thyroid tissue on DWI were measured as: SIRb0, SIRb800 and SIRb2000. Apparent diffusion coefficient (ADC) values based on the 3 different b-values were acquired as: ADCb0-800, ADCb0-2000, and ADCb0-800-2000. The 6 diagnostic indicators were evaluated by receiver operating characteristic (ROC) and diagnostic ability was compared between high b-value DWI and Ultrasound (US). Results A total of 52 PTCs including 33 PTMCs (38 patients, 8 men and 30 women, aged 45.68 ± 11.93 years) and 62 benign thyroid nodules (46 patients, 7 men and 39 women, aged 48.73 ± 11.98 years) were enrolled into the final statistical analysis. ADCb0-800-2000 had the highest diagnostic ability in differentiating PTCs from benign thyroid nodules with area under curve (AUC) of 0.944, sensitivity of 96.15% and specificity of 85.48%, and PTMCs from benign thyroid nodules with AUC of 0.940, sensitivity of 93.94% and specificity of 85.48%. On the strength of lower false-positive rates than US (14.52% vs. 32.26% for PTCs and 14.52% vs. 32.26% for PTMCs), ADCb0-800-2000 had significantly better diagnostic ability in PTCs (P = 0.002) and PTMCs (P = 0.005). Conclusion High b-value (2000 sec/mm2) DWI can contribute to differentiating PTCs and PTMCs from benign thyroid nodules and can be potentially used as an active surveillance imaging method for PTMCs.
Collapse
Affiliation(s)
- Qingjun Wang
- Department of Radiology, Chinese Navy General Hospital of PLA, Beijing, China
| | - Yong Guo
- Department of Radiology, Chinese Navy General Hospital of PLA, Beijing, China
- * E-mail:
| | - Jing Zhang
- Department of Radiology, Chinese Navy General Hospital of PLA, Beijing, China
| | - Lijing Shi
- Department of Radiology, Chinese Navy General Hospital of PLA, Beijing, China
| | - Haoyong Ning
- Department of Pathology, Chinese Navy General Hospital of PLA, Beijing, China
| | - Xiliang Zhang
- Department of General Surgery, Chinese Navy General Hospital of PLA, Beijing, China
| | - Yuanyuan Lu
- Department of Ultrasound, Chinese Navy General Hospital of PLA, Beijing, China
| |
Collapse
|
18
|
Xiong L, Ding L, Ning H, Wu C, Fu K, Wang Y, Zhang Y, Liu Y, Zhou L. CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells. Oncotarget 2018; 7:57737-57751. [PMID: 27363028 PMCID: PMC5295386 DOI: 10.18632/oncotarget.10252] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2016] [Accepted: 05/04/2016] [Indexed: 11/25/2022] Open
Abstract
Trastuzumab is widely used in the clinical treatment of human epidermal growth factor receptor-2 (HER2)-positive breast cancer, but the patient response rate is low. CD147 stimulates cancer cell proliferation, migration, metastasis and differentiation and is involved in chemoresistance in many types of cancer cells. Whether CD147 alters the effect of trastuzumab on HER2-positive breast cancer cells has not been previously reported. Our study confirmed that CD147 suppression enhances the effects of trastuzumab both in vitro and in vivo. CD147 suppression increased the inhibitory rate of trastuzumab and cell apoptosis in SKBR3, BT474, HCC1954 and MDA-MB453 cells compared with the controls. Furthermore, CD147 knockdown increased expression of cleaved Caspase-3/9 and poly (ADP-ribose) polymerase (PARP) and decreased both mitogen-activated protein kinase (MAPK) and Akt phosphorylation in the four cell lines. In an HCC1954 xenograft model, trastuzumab achieved greater suppression of tumor growth in the CD147-knockdown group than in the shRNA negative control (NC) group. These data indicated that enhancement of the effect of trastuzumab on HER2-positive cells following CD147 knockdown might be attributed to increased apoptosis and decreased phosphorylation of signaling proteins. CD147 may be a key protein for enhancing the clinical efficacy of trastuzumab.
Collapse
Affiliation(s)
- Lijuan Xiong
- Central Laboratory, Navy General Hospital, Beijing 100048, P.R. China
| | - Li Ding
- The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510630, P.R.China
| | - Haoyong Ning
- Department of Pathology, Navy General Hospital, Beijing 100048, P.R. China
| | - Chenglin Wu
- Central Laboratory, Navy General Hospital, Beijing 100048, P.R. China
| | - Kaifei Fu
- Central Laboratory, Navy General Hospital, Beijing 100048, P.R. China
| | - Yuxiao Wang
- Central Laboratory, Navy General Hospital, Beijing 100048, P.R. China
| | - Yan Zhang
- Department of Surgery, Navy General Hospital, Beijing 100048, P.R. China
| | - Yan Liu
- The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510630, P.R.China
| | - Lijun Zhou
- Central Laboratory, Navy General Hospital, Beijing 100048, P.R. China
| |
Collapse
|
19
|
Valle L, Rowe L, Krauze A, Kaushal A, Arora B, Ning H, Cooley-Zgela T, Schott E, Choyke P, Turkbey B, Citrin D. The Response of Male Erectile Tissues to Androgen Deprivation Therapy and Radiation. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Rowe L, Butman J, Mackey M, Shih J, Ning H, Cooley-Zgela T, Gilbert M, Smart D, Camphausen K, Krauze A. Response Assessment in Glioblastoma: A Clinical Experience. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Wu H, Wang D, Meng Y, Ning H, Liu X, Xie Y, Cui L, Wang S, Xu X, Peng R. Activation of TLR signalling regulates microwave radiation-mediated impairment of spermatogenesis in rat testis. Andrologia 2017; 50. [PMID: 28782295 DOI: 10.1111/and.12828] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/09/2017] [Indexed: 02/06/2023] Open
Affiliation(s)
- H. Wu
- Department of Pathology; Navy General Hospital; Beijing China
| | - D. Wang
- Beijing Institute of Radiation Medicine; Beijing China
| | - Y. Meng
- Department of Pathology; Navy General Hospital; Beijing China
| | - H. Ning
- Department of Pathology; Navy General Hospital; Beijing China
| | - X. Liu
- Department of Pathology; Navy General Hospital; Beijing China
| | - Y. Xie
- Beijing Institute of Radiation Medicine; Beijing China
| | - L. Cui
- Beijing Institute of Radiation Medicine; Beijing China
| | - S. Wang
- Beijing Institute of Radiation Medicine; Beijing China
| | - X. Xu
- Beijing Institute of Radiation Medicine; Beijing China
| | - R. Peng
- Beijing Institute of Radiation Medicine; Beijing China
| |
Collapse
|
22
|
Li H, Wu A, Reed-Maldonado A, Ning H, Banie L, Wang L, Lee Y, Xin Z, Guo Y, Lin G, Lue T. 144 Therapeutic Mechanism of Low Intensity Extracorporeal Shock Wave in Ameliorating Neurogenic Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rat Model. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2016.11.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
23
|
Valle L, Greer M, Muthigi A, Krauze A, Kaushal A, Su D, Pinto P, Wood B, Merino M, Ning H, Arora B, Cooley-Zgela T, Choyke P, Turkbey B, Citrin D. Assessment of Multiparametric Magnetic Resonance Imaging for the Detection of Local Recurrence After Low-Dose-Rate Brachytherapy. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.1240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Krauze A, Cheng J, Ning H, Hawes M, Mackey M, Zgela TC, Smart D, Citrin D, Rowe L, Camphausen K. Deformable Registration for Estimation of Cumulative Dose and Normal Tissue Complication Probability in Patients Receiving Reirradiation for Recurrent High-Grade Glioma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Rowe L, Mackey M, Smart D, Ning H, Gilbert M, Camphausen K, Krauze A. Outcomes and Prognostic Features of Glioblastoma Multiforme in the Temozolomide Era. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
26
|
Zhuge Y, Ning H, Cheng J, Kirkland R, Arora B, Miller R, Kaushal A, Camphausen K, Krauze A. A Novel Approach to Diffusion Weighted Imaging Analysis in Newly Diagnosed GBM. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
27
|
Padro D, Eisch R, Bates S, Simone C, Ning H, Smart D, Jones J, Krauze A, Citrin D, Kesarwala A, Camphausen K, Kaushal A. Salvage Radiation Therapy for Chemotherapy Refractory Cutaneous Mycosis Fungoides. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
28
|
Li X, Liu W, Wang H, Yang L, Li Y, Wen H, Ning H, Wang J, Zhang L, Li J, Fan D. Rap1 is indispensable for TRF2 function in etoposide-induced DNA damage response in gastric cancer cell line. Oncogenesis 2015; 4:e144. [PMID: 25821946 PMCID: PMC4491608 DOI: 10.1038/oncsis.2015.1] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Revised: 01/19/2015] [Accepted: 01/21/2015] [Indexed: 12/14/2022] Open
Abstract
The telomeric protein TRF2, involving in telomeric and extratelomeric DNA damage response, has been previously reported to facilitate multidrug resistance (MDR) in gastric cancer cells by interfering ATM-dependent DNA damage response induced by anticancer drugs. Rap1 is the TRF2-interacting protein in the shelterin complex. Complex formation between Rap1 and TRF2 is essential for their function in telomere and end protection. Here we focus on the effects of Rap1 on TRF2 function in DNA damage response induced by anticancer drugs. Both Rap1 and TRF2 expression were upregulated in SGC7901 and its MDR variant SGC7901/VCR after etoposide treatment, which was more marked in SGC7901/VCR than in SGC7901. Rap1 silencing by siRNA in SGC7901/VCR partially reversed the etoposide resistance. And Rap1 silencing partially reversed the TRF2-mediated resistance to etoposide in SGC7901. Rap1 silencing did not affect the TRF2 upregulation induced by etoposide, but eliminated the inhibition effect of TRF2 on ATM expression and ATM phosphorylation at serine 1981 (ATM pS1981). Furthermore, phosphorylation of ATM targets, including γH2AX and serine 15 (S15) on p53, were increased in Rap1 silencing cells in response to etoposide. Thus, we confirm that Rap1, interacting with TRF2 in the shelterin complex, also has an important role in TRF2-mediated DNA damage response in gastric cancer cells treated by etoposide.
Collapse
Affiliation(s)
- X Li
- Department of Neurology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - W Liu
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - H Wang
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L Yang
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Y Li
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - H Wen
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - H Ning
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Wang
- Department V of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L Zhang
- Department II of Digestive Diseases, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Li
- Department of Neurology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - D Fan
- State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, China
| |
Collapse
|
29
|
Zhuge Y, Ning H, Cheng J, Arora B, Xie H, Miller R. SU-E-I-51: Metal Artifact Reduction in CT Using Deformable Tissue-Class Modeling. Med Phys 2013. [DOI: 10.1118/1.4814161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
30
|
|
31
|
Behera MK, Sharma A, Dutta S, Sharma S, Julka PK, Rath GK, Kil WJ, Ko C, Kaushal A, Warran K, Ning H, Camphausen K, Smart D, Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD, Jensen RL, Shrieve DC, Mohindra P, Robins HI, Tome WA, Howard SP, Chen C, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Kavanagh BD, Wang CC, Floyd S, Chang CH, Warnke P, Chio CC, Kasper E, Mahadevan A, Wong E, Jeyapalan S, Chen C, Mahajan A, Grosshans D, McAleer MF, Brown PD, Chintagumpala M, Vats T, Puduvalli V, Yock T, Schulder M, Herschmann Y, Ghaly M, Knisely J, Ghaly M, Kapur A, Schulder M, Knisely J, Goetz P, Lwu S, Ebinu J, Arayee M, Monsalves E, Laperriere N, Menard C, Bernstein M, Zadeh G, Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson A, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL, Lwu S, Goetz P, Aryaee M, Monsalves E, Laperriere N, Menard C, Bernstein M, Zadeh G, Mahajan A, Lowe C, McAleer MF, Grosshans D, DeGroot J, Mark G, Vats T, Brown PD, Ruda R, Trevisan E, Magliola U, Bertero L, Bosa C, Ricardi U, Soffietti R, Rajappa P, Margetis K, Wernicke AG, Sherr DL, Lavi E, Fine RL, Schwartz T, Pannullo SC, Laack N, Blanchard M, Buckner J, Glass J, Andrews DW, Werner-Wasik M, Evans J, Lawrence YR, Shi W, Strauss I, Corn BW, Matceyevsky D, Alani S, Gez E, Shtraus N, Kanner AA, Spasic M, Choy W, Nagasawa D, Yang I, Noel M, Woolf E, Smith R, Castillo-Rojas P, Sorenson S, Smith K, Scheck AC, Han SJ, Oh MC, Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, Parsa AT, Redmond KJ, Horska A, Ishaq O, Ford E, McNutt T, Batra S, Kleinberg L, Wharam M, Mahone M, Terezakis S, Ryu S, Rock J, Movsas B, Mikkelsen T, Rosenblum M, Sabsevitz D, Bovi JA, Leo P, LaViolette P, Rand S, Mueller W, Phillips A, Venkatramani R, Olch A, Grimm J, Davidson T, Brown R, Dhall G, Finlay J, Wong K. RADIATION THERAPY. Neuro Oncol 2011. [DOI: 10.1093/neuonc/nor160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
32
|
Ko C, Ménard C, Ning H, Lita E, Smith S, Pinto P, Singh A, Coleman C, Camphausen K, Kaushal A. Intrarectal Amifostine Suspension During External Beam Radiotherapy For Prostate Cancer May Protect Against Long-term Toxicity. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
33
|
Zhuge Y, Xie H, Ning H, Cheng J, Arora B, Han-Oh Y, Miller R. SU-E-J-59: GPU-Based Interactive Multi-Volume Visualization in Radiotherapy Treatment Planning. Med Phys 2011. [DOI: 10.1118/1.3611827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
34
|
Ning H, Chin B, Cheng J, Zhuge Y, Xie H, Ondo J, Kaushal A, Miller R. SU-E-T-526: Is the Marker Matching Method Adequate for Daily Setup of Pelvic Fields in Prostate Irradiation? Med Phys 2011. [DOI: 10.1118/1.3612479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
35
|
Ning H, Chin B, Cheng J, Miller R. SU-E-T-806: IMRT Technique for CSI: Better Dose Distribution, Simplified Setup, No Need to Shift Junctions. Med Phys 2011. [DOI: 10.1118/1.3612770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
36
|
Han-Oh S, Cheng J, Ning H, Arora B, Zhuge Y, Xie H, Ondos J, Miller R. SU-E-T-90: Determination of Orthovoltage Beam-Hardening Filters Generating the NIST-Traceable Beam Quality. Med Phys 2011. [DOI: 10.1118/1.3612041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
37
|
Ko C, Ning H, Camphausen K, Smith S, McNally D, Choyke P, Lita E, Coleman N, Menard C, Kaushal A. Phase II Trial of Combined High-dose-Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate: Long-term Follow-up of Trial NCI 02-C-0207. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Li G, Xie H, Miller D, Zhuge Y, Klein E, Low D, Ning H, Citrin D, Camphausen K, Miller R. Investigation of using Optical Surface Imaging for Volumetric Prediction of Respiratory Organ Motion. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
39
|
Housri N, Ondos J, Choyke P, Barbara A, Ning H, Citrin D, Singh A, Kaushal A. Tumor Nodule Location Predicts the Feasibility of Intraprostatic High-dose Irradiation in Men with Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Yang R, Lin G, Ning H, Guo H, Dai Y, Sun Z, Lin C, Lue T. UP-3.101: Notable Promotion of Neurite Out Growth in Major Pelvic Ganglion through Cytokine Secretion by Adipose Stem Cells. Urology 2009. [DOI: 10.1016/j.urology.2009.07.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
41
|
Li G, Ning H, Xie H, Guion P, Citrin D, Zach L, Simone N, Kaushal A, Camphausen K, Miller R. SU-FF-J-113: A Simplified 4DRT Strategy Using a 3.5D Approach and 3D Planning Tools: A Dual Motion Phantom Study. Med Phys 2009. [DOI: 10.1118/1.3181405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
42
|
Li G, Xie H, Ning H, Low D, Citrin D, Zach L, Simone N, Kaushal A, Camphausen K, Miller R. SU-FF-J-125: A Simplified 4DRT Strategy Using a 3.5D Approach and 3D Planning Tools: A Planning Comparison Study. Med Phys 2009. [DOI: 10.1118/1.3181417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
43
|
Ning H, Yang F, Jiang M, Hu L, Feng K, Zhang J, Yu Z, Li B, Xu C, Li Y, Wang J, Hu J, Lou X, Chen H. Reply to “Reply to ‘The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study’ by Ning H et al.” by Behre et al. Leukemia 2009. [DOI: 10.1038/leu.2008.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
44
|
Li G, Ning H, Brown A, Citrin D, Xie H, Chang J, Arora B, Capala J, Camphausen K, Miller R. Image Guided, Motion-free Patient Body Setup using 3D Volumetric Image Registration of Classified Stable Bony Landmarks. Int J Radiat Oncol Biol Phys 2008. [DOI: 10.1016/j.ijrobp.2008.06.072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z, Fan D. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract 2008; 62:1056-62. [PMID: 17537188 DOI: 10.1111/j.1742-1241.2007.01368.x] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Osteopontin (OPN) was shown to play an important role in the pathogenesis of various inflammatory and fibrotic processes and elevated in fibrotic liver of mouse model. However, the significance of OPN in hepatitis B virus (HBV)-induced liver cirrhosis (LC) remains unclear and is therefore evaluated in this study. METHODS Thirty-nine patients with HBV-induced LC, 30 patients with HBV infection but without cirrhosis, 11 patients with HBV-related hepatocellular carcinoma (HCC) and 14 additional healthy controls were enrolled in this study. Plasma levels of OPN were measured with enzyme-linked immunosorbent assay and the relationship between OPN and clinical parameters was evaluated. RESULTS When compared to HBV infection group (median 2.16 ng/ml), plasma levels of OPN were significantly increased in cirrhosis (4.52 ng/ml, p < 0.001) and cancer group (13.38 ng/ml, p < 0.001). The OPN level was correlated with the severity of liver damage according to Child-Pugh classification (p = 0.003). It showed at least comparable sensitivity and specificity to predict cirrhosis as aspartate aminotransferase to platelet ratio index, a previously established non-invasive serum marker of cirrhosis. CONCLUSIONS These data suggest that OPN could be used to evaluate the existence of LC, as OPN has previously been reported to be increased in the HCC; this unique feature makes OPN a promising candidate for prediction biomarker in the long-time surveillance of patients with HBV infection to evaluate the risk of cirrhosis and cancer.
Collapse
Affiliation(s)
- L Zhao
- State Key Laboratory of Cancer Biology & Institute of Gastroenterology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Beijing, China.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Ning H, Yang F, Jiang M, Hu L, Feng K, Zhang J, Yu Z, Li B, Xu C, Li Y, Wang J, Hu J, Lou X, Chen H. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 2008; 22:593-9. [PMID: 18185520 DOI: 10.1038/sj.leu.2405090] [Citation(s) in RCA: 259] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
In this open-label randomized clinical trial, HLA-identical sibling-matched hematopoietic stem cells (HSC) were transplanted (non-MSCs group, n=15) or cotransplanted with mesenchymal stem cells (MSCs) (MSCs group, n=10) in hematologic malignancy patients. The median number of MSCs infused was 3.4 x 10(5) kg(-1) (range, 0.3-15.3 x 10(5) kg(-1)). MSCs infusions were well tolerated. The median time to neutrophil engraftment (absolute neutrophil count >0.5 x 10(9) l(-1)) was 16 days for MSCs group and 15 days for non-MSCs group. The median time to platelet engraftment (platelet count >50 x 10(9) l(-1)) was 30 and 27 days, respectively. Grades II-IV acute graft-versus-host disease (GVHD) was observed respectively, in one (11.1%) and eight (53.3%) evaluable patients. Chronic GVHD was found in one (14.3%) and four (28.6%) evaluable patients. The number of patients who relapsed were six (60.0%) and three (20.0%), and the 3-year disease-free survivals were 30.0 and 66.7%, respectively. Thus cotransplantation of MSCs and HSCs may prevent GVHD, but the relapse rate is obviously higher than the control group. We conclude that use of MSCs must be handled with extreme caution before a large-scale clinical trial is performed.
Collapse
Affiliation(s)
- H Ning
- Department of Hematopoietic Stem Cell Transplantation, Affiliated Hospital to Academy of Military Medical Sciences, Beijing, People's Republic of China
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Li G, Guion P, Ning H, Citrin D, Xie H, Capala J, Arora B, Camphausen K, Singh A, Miller R. A Pancreas Motion Study Using Automatic Image Segmentation of Time-Resolved, Single-Slice MR Images. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.2289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Miller R, Ning H, Justus B, Huston A, Li G, Chang J, Capala J, Xie H, Citrin D, Camphausen K. Use of an Optical Fiber Dosimeter to Measure Small Field Output Factors in Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.1990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Soule BP, Simone NL, Savani BN, Ning H, Albert PS, Barrett AJ, Singh AK. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant 2007; 40:573-8. [PMID: 17637691 DOI: 10.1038/sj.bmt.1705771] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Our purpose was to determine if total body irradiation (TBI) with lung dose reduction protects against subsequent radiation-induced deterioration in pulmonary function. Between July 1997 and August 2004, 181 consecutive patients with hematologic malignancies received fractionated TBI before allogeneic peripheral blood stem cell transplant. The first 89 patients were treated to a total dose of 13.6 Gy. Thereafter, total body dose was decreased to 12 Gy with lung dose reduction to 9 or 6 Gy. All patients underwent pulmonary function test evaluation before treatment, 90 days post-treatment, then annually. Median follow-up was 24.0 months. Eighty-nine patients were treated with lung shielding, and 92 without. At 1-year post transplant, there was a small but significant difference in lung volume measurements between patients with lung shielding and those without. This was not observed at the 2-year time point. When stratified by good (>100% predicted) or poor (</=100% predicted) baseline lung function, patients with poor function demonstrated protection at 1 year with lung shielding, while those with good initial lung function did not. TBI with or without lung dose reduction has a small but statistically significant effect on pulmonary function measured at 1 year but not 2 years post irradiation.
Collapse
Affiliation(s)
- B P Soule
- Radiation Biology Branch, National Cancer Institute, NIH, Bethesda, MD, USA
| | | | | | | | | | | | | |
Collapse
|
50
|
Ushino T, Justus B, Huston A, Ning H, Miller R, Al-Ghazi M. SU-FF-T-369: Real-Time Optical Fiber in Vivo Dosimeter with a Novel Method for Eliminating the “stem Effect”. Med Phys 2007. [DOI: 10.1118/1.2761094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|